SN
Saraswathi Nekkanti
About Saraswathi Nekkanti
Data last updated:
Saraswathi Nekkanti is a Director at Srinija Drugs Private Limited (since 2023). The company operates in Pharma. Srinija Drugs Private Limited reported revenue of ₹19.09 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Srinija Drugs Private Limited U24233AP2000PTC034263 | Director | 28 Oct 2023 | 2000 | ₹19.09 Cr (FY 2024) | Active |
Board colleagues of Saraswathi Nekkanti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anantha Laxmi Talluri | 07690076 | Srinija Drugs Private Limited | Director |
| Bulli Raju Nekkanti | 01746430 | Srinija Drugs Private Limited | Managing Director |
| Laxmanarao Talluri | 01746373 | Srinija Drugs Private Limited | Director |
| Venkata Ramesh Donavalli | 01746408 | Srinija Drugs Private Limited | Director |
| Venkata Satyavani Donavalli | 07690103 | Srinija Drugs Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saraswathi Nekkanti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saraswathi Nekkanti
Saraswathi Nekkanti currently holds 1 directorship: Srinija Drugs Private Limited (Director, since 28 Oct 2023, revenue ₹19.09 Cr (FY 2024)).
Saraswathi Nekkanti was first appointed on 28 Oct 2023 as Director at Srinija Drugs Private Limited.
The current boards of Saraswathi Nekkanti's companies include Anantha Laxmi Talluri (Srinija Drugs Private Limited), Bulli Raju Nekkanti (Srinija Drugs Private Limited), Laxmanarao Talluri (Srinija Drugs Private Limited), Venkata Ramesh Donavalli (Srinija Drugs Private Limited), Venkata Satyavani Donavalli (Srinija Drugs Private Limited).